Cointime

IMMUNETHEP

company

About

Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies

  • 1 - 10

Highlights

Total Funding Amount
€2.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Oct 16, 2013
Number Of Employee
1 - 10
Operating Status
Active

Immunethep is a biotechnology company focused on drug development for Immune System related pathologies.
Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs.
Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
IMMUNETHEP has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Oct 18, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 18, 2022 Grant €2.50M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
IMMUNETHEP is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท